全文获取类型
收费全文 | 216757篇 |
免费 | 4415篇 |
国内免费 | 149篇 |
专业分类
耳鼻咽喉 | 1555篇 |
儿科学 | 7731篇 |
妇产科学 | 3735篇 |
基础医学 | 21758篇 |
口腔科学 | 2689篇 |
临床医学 | 17572篇 |
内科学 | 40051篇 |
皮肤病学 | 1785篇 |
神经病学 | 19928篇 |
特种医学 | 10200篇 |
外科学 | 33499篇 |
综合类 | 2858篇 |
一般理论 | 32篇 |
预防医学 | 22453篇 |
眼科学 | 3361篇 |
药学 | 12568篇 |
中国医学 | 715篇 |
肿瘤学 | 18831篇 |
出版年
2023年 | 241篇 |
2022年 | 388篇 |
2021年 | 899篇 |
2020年 | 532篇 |
2019年 | 873篇 |
2018年 | 22798篇 |
2017年 | 17913篇 |
2016年 | 20198篇 |
2015年 | 1794篇 |
2014年 | 2040篇 |
2013年 | 2521篇 |
2012年 | 9513篇 |
2011年 | 23480篇 |
2010年 | 20078篇 |
2009年 | 12768篇 |
2008年 | 21618篇 |
2007年 | 23785篇 |
2006年 | 2752篇 |
2005年 | 4374篇 |
2004年 | 5350篇 |
2003年 | 6232篇 |
2002年 | 4303篇 |
2001年 | 1312篇 |
2000年 | 1473篇 |
1999年 | 1121篇 |
1998年 | 644篇 |
1997年 | 592篇 |
1996年 | 455篇 |
1995年 | 451篇 |
1994年 | 370篇 |
1993年 | 351篇 |
1992年 | 702篇 |
1991年 | 747篇 |
1990年 | 741篇 |
1989年 | 630篇 |
1988年 | 560篇 |
1987年 | 537篇 |
1986年 | 529篇 |
1985年 | 533篇 |
1984年 | 388篇 |
1983年 | 342篇 |
1982年 | 271篇 |
1981年 | 237篇 |
1980年 | 228篇 |
1979年 | 343篇 |
1978年 | 261篇 |
1977年 | 213篇 |
1974年 | 244篇 |
1973年 | 216篇 |
1971年 | 193篇 |
排序方式: 共有10000条查询结果,搜索用时 671 毫秒
61.
Irwin L. Flink 《Brain structure & function》2002,205(3):235-244
62.
Rapid adenosine release in the nucleus tractus solitarii during defence response in rats: real-time measurement in vivo 总被引:6,自引:3,他引:3
Nicholas Dale Alexander V. Gourine Enrique Llaudet David Bulmer Teresa Thomas† K. Michael Spyer 《The Journal of physiology》2002,544(1):149-160
We have measured the release of adenosine and inosine from the dorsal surface of the brainstem and from within the nucleus tractus solitarii (NTS) during the defence response evoked by hypothalamic stimulation in the anaesthetised rat. At the surface of the brainstem, only release of inosine was detected on hypothalamic defence area stimulation. This inosine signal was greatly reduced by addition of the ecto-5'-nucleotidase inhibitor α,β-methylene ADP (200 μM), suggesting that the inosine arose from adenosine that was produced in the extracellular space by the prior release of ATP. By placing a microelectrode biosensor into the NTS under stereotaxic control we have recorded release of adenosine within this nucleus. By contrast to the brainstem surface, a fast increase in adenosine, accompanied only by a much smaller change in inosine levels, was seen following stimulation of the hypothalamic defence area. The release of adenosine following hypothalamic stimulation was mainly confined to a narrow region of the NTS some 500 μm in length around the level of the obex. Interestingly the release of adenosine was depletable: when the defence reaction was evoked at short time intervals, much less adenosine was released on the second stimulus. Our novel techniques have given unprecedented real-time measurement and localisation of adenosine release in vivo and demonstrate that adenosine is released at the right time and in sufficient quantities to contribute to the cardiovascular components of the defence reaction. 相似文献
63.
The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference 总被引:7,自引:0,他引:7
We investigated the involvement of the hippocampal formation and the amygdala in the acquisition and expression of the amphetamine-produced conditioned place preference (CPP). Animals were conditioned in four sessions that included two pairings of d-amphetamine (2.0 mg/kg, s.c.) with one of two distinct compartments and two pairings of vehicle with the other compartment in a counterbalanced manner. Animals' preferences for the compartments were then tested in the absence of amphetamine. The CPP was attenuated by preconditioning electrolytic or excitotoxic lesions of the lateral nucleus of amygdala, but not by electrolytic lesions of the central or basolateral nucleus of amygdala, endopiriform nucleus, or ventral hippocampus or by radio-frequency lesions of the fornix-fimbria. When the lateral nucleus of amygdala was damaged by electrolytic or excitotoxic lesions after conditioning, animals failed to express an amphetamine-produced CPP. These results demonstrate that expression of the amphetamine-produced CPP is mediated by intrinsic neurons of the lateral nucleus of the amygdala, and that neither acquisition nor expression of the CPP is mediated by the central or basolateral amygdaloid nucleus or the hippocampus-accumbens projection. Combined with our previous finding that the expression of the amphetamine-produced CPP is also mediated by dopamine receptor activation in the nucleus accumbens (Hiroi and White, 1989, 1990), it could be suggested that the lateral nucleus of the amygdala and dopamine terminals in the nucleus accumbens are parts of the neural circuitry that mediates the expression of the amphetamine-produced CPP. 相似文献
64.
65.
66.
67.
68.
69.
70.
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies
Bayard L. Powell Hyman B. Muss Robert L. Capizzi Mary E. Caponera Douglas R. White Patricia J. Zekan James N. Atkins Don V. Jackson Jr. Frederick Richards II John B. Craig Julia M. Cruz Charles L. Spurr 《Cancer chemotherapy and pharmacology》1987,19(3):250-252
Summary Cytosine arabinsodie (ara-C) and etoposide (VP-16) display synergy in the laboratory. Twenty-six patients participated in a phase I study of high-dose ara-C in combination with VP-16. The dose of VP-16 was held constant at 50 mg/m2 as an intermittent infusion over 33 h; escalating doses of ara-C were given as infusions during hours 9–12 and 21–24. Myelosuppression was the dose-limiting toxicity and occurred with doses considerably less than those expected from studies of the two drugs as single agents. The suggested initial doses for phase II trials with this schedule are 750 mg/m2×2 doses of ara-C and 50 mg/m2 of VP-16. Nonhematologic toxicity was minimal; therefore, further dose escalation is feasible in patients in whom myelosuppression is acceptable.Supported in part by grants from the National Cancer Institute (CA-12197 and CA-09422) and the American Cancer Society CF-85-182 相似文献